Form 4: TransDigm Director Exercises Options, Sells Shares
Insider Transaction Report
TransDigm Group Director Kevin Stein exercised stock options and subsequently sold an equivalent number of shares through a pre-planned trading arrangement.
Summary
- Kevin M. Stein, a Director of TransDigm Group INC (TDG), engaged in a series of transactions on November 20, 2025.
- Exercised 1,104 stock options at an exercise price of $105.88 per share, an amount adjusted for dividends declared since August 1, 2022.
- Simultaneously sold 1,104 shares of common stock in multiple transactions at weighted average prices ranging from approximately $1,360.33 to $1,363.22 per share.
- The transactions were conducted pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
- Following these transactions, beneficial ownership of common stock held indirectly through the Fortuna Trust dated June 1, 2018, decreased from 9,262 shares to 8,158 shares.
- The number of derivative securities (stock options) beneficially owned indirectly through the Fortuna Trust decreased from 65,609 to 64,505.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine, pre-planned insider transaction (exercise of options and subsequent sale of shares) that does not indicate a significant change in company prospects or management's view beyond personal financial planning.
Positives
- The transactions were executed under a Rule 10b5-1(c) plan, indicating they were pre-planned and not based on immediate, non-public information.
- The director realized a significant gain on the exercised options, selling shares at prices over $1,360 after exercising at $105.88.
Negatives
- A director's sale of shares, even if pre-planned, reduces their direct equity stake in the company, which some investors might interpret as a slight reduction in conviction.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for TransDigm Group.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/20/2025 | This indicates adherence to best practices for insider trading compliance, mitigating concerns about opportunistic trading based on non-public information. |
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, pre-planned insider transaction. The director's indirect common stock holdings decreased slightly, but the transaction itself is not indicative of company performance or strategic shifts.
Key Dates
| Date | Description |
|---|---|
| 09/30/2018 | Date exercisable for the stock option |
| 11/20/2025 | Transaction date for option exercise and share sales |
| 11/21/2025 | Signature date of the filing |
| 04/25/2028 | Expiration date for the stock option |
Keywords
TransDigm Group, TDG, Kevin Stein, Director, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.